Acorda Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
16,441.00
17,672.00
11,058.00
35,603.00
223,359.00
33,682
Depreciation, Depletion & Amortization
6,999.00
8,473.00
15,012.00
21,582.00
23,234.00
11,479
Other Funds
91.00
-
194.00
56.00
50,787.00
72,529
Funds from Operations
60,402.00
79,196.00
63,975.00
20,118.00
123,663.00
103,185
Changes in Working Capital
21,220.00
4,247.00
20,294.00
9,531.00
26,906.00
47,608
Net Operating Cash Flow
39,182.00
74,949.00
43,681.00
29,649.00
96,757.00
150,793
Capital Expenditures
7,164.00
7,783.00
7,066.00
7,085.00
14,376.00
Sale of Fixed Assets & Businesses
-
-
-
-
6,385.00
Purchase/Sale of Investments
30,429.00
190,109.00
78,170.00
199,751.00
-
Net Investing Cash Flow
45,092.00
293,825.00
85,236.00
101,732.00
7,991.00
Issuance/Reduction of Debt, Net
909.00
336,922.00
875.00
1,587.00
2,409.00
Net Financing Cash Flow
11,968.00
352,937.00
17,415.00
73,877.00
58,797.00
Net Change in Cash
6,058.00
134,062.00
24,140.00
365.00
148,788.00
Free Cash Flow
35,139.00
69,865.00
37,760.00
23,457.00
83,069.00
Deferred Taxes & Investment Tax Credit
9,520.00
6,681.00
3,975.00
11,190.00
54,044.00
14,505
Net Assets from Acquisitions
7,499.00
476,151.00
-
294,400.00
-
Change in Capital Stock
12,786.00
16,015.00
18,096.00
75,520.00
10,419.00
Exchange Rate Effect
-
1.00
-
2,159.00
1,225.00
About Acorda Therapeutics
View Profile
